MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-MH-18-0050516
Aurazen Pharmaceutical Private Limited
Aurazen Pharmaceutical Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹12.08 Lakh
▲ 4731% YoY
Net loss · FY 2025
₹1.32 Lakh
Net margin -10.9%
EBITDA · FY 2025
-₹1.3 Lakh
EBITDA margin -10.8%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Aurazen Pharmaceutical Private Limited
Data last updated:
Aurazen Pharmaceutical Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 December 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2020PTC352076. Its GSTIN is 27AAUCA5352Q1ZS (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Rutuja Yatin Shelar and Shreeya Yatin Shelar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Wadhwa 1604 C – Wing Atmosphere Realty Suburban Greater Mumbai Mulund W, Maharashtra, India – 400080.
As per the financials filed for FY 2025, the company reported a revenue of ₹12.08 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹1.32 Lakh (net margin -10.9%) and EBITDA of -₹1.3 Lakh (EBITDA margin -10.8%). Revenue has grown at a compounded annual rate (CAGR) of 76% over three years.
Aurazen Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0050516).
Company details
CIN U24100MH2020PTC352076
Registration Number 352076
Incorporation Date 17 December 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-18-0050516
Recognitions & Rankings of Aurazen Pharmaceutical
Contact details
Aurazen Pharmaceutical Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressWadhwa 1604 C – Wing Atmosphere Realty Suburban Greater Mumbai Mulund W, Maharashtra, India – 400080
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Aurazen Pharmaceutical Private Limited, buy the company report.
Comprehensive company report
Aurazen Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Aurazen Pharmaceutical is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Aurazen Pharmaceutical Private Limited, buy the company report.
Financials of Aurazen Pharmaceutical Private Limited
FY 2025 filings availableAurazen Pharmaceutical Private Limited reported revenue of ₹12.08 Lakh (up 4731% YoY) for FY 2025.
Revenue · FY 2025
₹12.08 Lakh ▲ 4731%
Net loss · FY 2025
₹1.32 Lakh margin -10.9%
EBITDA · FY 2025
-₹1.3 Lakh margin -10.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
3 years · compounded
▲ 76%
EBITDA CAGR growth
1 year
▲ 39%
3 years · compounded
▲ 44%
Revenue has grown at a compounded annual rate (CAGR) of 76% over three years. EBITDA rose 39% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.3 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.32 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -10.8% | ||||
| Net Profit Margin | -10.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aurazen Pharmaceutical Private Limited, buy the company report.
Board of directors of Aurazen Pharmaceutical Private Limited
Aurazen Pharmaceutical has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rutuja Yatin Shelar | Director | 17 Dec 2020 | 5 Years 10 Months | Current |
| Shreeya Yatin Shelar | Director | 08 Aug 2022 | 4 Years 2 Months | Current |
| Sugandha Sunil Kubal | Director | 21 Aug 2023 | 3 Years 2 Months | Current |
Peer comparison
Aurazen Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sarsindhu Agro Farmer Producer Company Limited | ₹12.13 Lakh (FY 2025) | 20.0% | Niphad, Maharashtra, India | |||
| Alfaint Mobile Accessories Private Limited | ₹12.12 Lakh (FY 2025) | -61.0% | Kolkata, West Bengal, India | |||
| Orbal Healthcare Private Limited | ₹12.11 Lakh (FY 2025) | 348.0% | Ahmedabad, Gujarat, India | |||
| Meclubes Healthcare Private Limited | ₹12.1 Lakh (FY 2025) | 109.0% | Rewari, Haryana, India | |||
| Ivytech Solutions Private Limited | ₹12.1 Lakh (FY 2025) | -20.0% | Mumbai, Maharashtra, India | |||
| Aurazen Pharmaceutical Private Limitedthis company | ₹12.08 Lakh (FY 2025) | -₹1.32 Lakh | -10.9% | 4731.0% | Mumbai, Maharashtra, India | |
| Agrim Forge and Fittings Private Limited | ₹12.07 Lakh (FY 2024) | Ator Nagla, Uttar Pradesh, India | ||||
| Azure Remedies Private Limited | ₹12.06 Lakh (FY 2024) | 62.0% | New Delhi, Delhi, India | |||
| Chhatrapal Industries Private Limited | ₹12.05 Lakh (FY 2025) | 6.0% | Prayagraj, Uttar Pradesh, India | |||
| Aapurti E-Mart India Private Limited | ₹12.05 Lakh (FY 2024) | 100.0% | Delhi, India | |||
| Reico Process Measurement Private Limited | ₹12.04 Lakh (FY 2024) | -30.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Aurazen Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Aurazen Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aurazen Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Aurazen Pharmaceutical Private Limited has 1 active EPFO establishment as of Mar 24, 2024.
Active EPFO establishments
1
GST
Aurazen Pharmaceutical has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAUCA5352Q1ZS | Maharashtra | Active | 02 Jan 2021 |
To see the full GST registrations and return filing status of Aurazen Pharmaceutical Private Limited, buy the company report.
Recent activity
Aurazen Pharmaceutical Private Limited has 5 board changes on record since 2020: 4 appointments and 1 cessation. The latest: Sugandha Sunil Kubal was appointed as Director on 21 Aug 2023.
AGM
Aurazen Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Aurazen Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Appointed
Sugandha Sunil Kubal was appointed as Director.
Ceased
Himanshu Alkesh Potdar ceased to be Director.
Appointed
Shreeya Yatin Shelar was appointed as Director.
Appointed
Himanshu Alkesh Potdar was appointed as Director.
Appointed
Rutuja Yatin Shelar was appointed as Director.
Incorporation
17 Dec 2020
Aurazen Pharmaceutical Private Limited was registered on 17 Dec 2020 with Roc Mumbai I & aged 5 years 10 months as per MCA records.
Frequently asked questions
Aurazen Pharmaceutical is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 December 2020 (6+ years old) and is registered under CIN U24100MH2020PTC352076.
Aurazen Pharmaceutical has 3 current directors:
- Rutuja Yatin Shelar - Director
- Shreeya Yatin Shelar - Director
- Sugandha Sunil Kubal - Director
The latest financial statements of Aurazen Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Aurazen Pharmaceutical is 27AAUCA5352Q1ZS, registered in Maharashtra.
The CIN (Corporate Identification Number) of Aurazen Pharmaceutical is U24100MH2020PTC352076. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aurazen Pharmaceutical was incorporated on 17 December 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Aurazen Pharmaceutical by revenue are Sarsindhu Agro Farmer Producer Company Limited, Alfaint Mobile Accessories Private Limited, Orbal Healthcare Private Limited, Meclubes Healthcare Private Limited, Ivytech Solutions Private Limited and 5 more, all in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles).
Sugandha Sunil Kubal was appointed as Director on 21 Aug 2023. Himanshu Alkesh Potdar ceased to be Director on 08 Aug 2022. Shreeya Yatin Shelar was appointed as Director on 08 Aug 2022. Aurazen Pharmaceutical has 5 board changes on record in total.
Yes, Aurazen Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-18-0050516).
The registered office of Aurazen Pharmaceutical is at Wadhwa 1604 C – Wing Atmosphere Realty Suburban Greater Mumbai Mulund W, Maharashtra, India – 400080.
Aurazen Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.